Neisseria gonorrhoeae: Difference between revisions

Revision as of 18:39, 27 August 2019

Resistance
- About 50% resistance to fluoroquinolones
- Rates of MDR gonorrhea is increasing in Canada, mostly driven by azithromycin resistance
- XDR gonorrhea is still rare in Canada ^[1]

Classically presents with tenosynovitis (often of wrists) or frank arthritis, with pustular lesions
Diagnosed with genital testing for gonorrhea, ± blood cultures or arthrocentesis

Resistance
- MDR gonorrhea: resistance to one of azithromycin or a cephalosporin
- XDR if resistance to both azithromycin and a cephalosporin

@@ Line 6: / Line 6: @@
 ** About 50% resistance to [[fluoroquinolones]]
 ** Rates of MDR gonorrhea is increasing in Canada, mostly driven by [[azithromycin]] resistance
+** XDR gonorrhea is still rare in Canada <ref>{{cite journal|title=Multidrug-resistant and extensively drug-resistant gonorrhea in Canada, 2012–2016|journal=CCDR|year=2019|volume=45|issue=2/3|pages=45–53|doi=10.14745/ccdr.v45i23a01}}</ref>
-** XDR gonorrhea is still rare in Canada [[CiteRef:CCDR2019]]
-{{#scite:CCDR2019|type=journal|title=Multidrug-resistant and extensively drug-resistant gonorrhea in Canada, 2012–2016|journal=CCDR|year=2019|volume=45|issue=2/3|pages=45–53|doi=10.14745/ccdr.v45i23a01}}
 == Clinical Presentation ==